White Papers

Sustainable Solutions for Cell Culture Media: Krakatoa™ Environmental Impact and Life Cycle Assessment

28 April 2022
Sustainable Solutions for Cell Culture Media Krakatoa

Cellular therapies and other biologics are being touted as medicines of the future, and rightfully so. These therapies have already shown great promise for treating cancer and other serious diseases.[1] Like any large commercial entity, however, the pharmaceutical industry comes with a hefty environmental impact. In fact, the global pharmaceutical industry contributes more to greenhouse gas (GHG) emissions than the global automotive sector.[2] In 2021, the global pharmaceuticals market was worth $1.17 trillion, with a growth rate of 5.8% over the 2017 market value.[3] Cell and Gene Therapy (CGT) and monoclonal antibodies (mAB) represent 40% of the product pipeline, outstripping small molecule products. As biologics, these products must be grown in large bioreactors, in sterile GMP grade liquid media that has a massive environmental footprint.

Share this article

Resources and Downloads

Explore all Stoic Bio educational resources and downloads. Learn how the Krakatoa ecoystem powers sustainable cell science.
Next generation advanced medicines are being introduced through improvements in biopharmaceutical innovation,...
Media pods are constructed from 96% biodegradable and recyclable components, bringing an environmentally friendly...
The development process of cell therapies is extensive and requires a unique combination of expensive reagents and...